Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Wins Deloitte Technology Fast 500 Asian Pacific 2005

December 13, 2005 - Shanghai, China - WuXi PharmaTech, the leading provider of chemistry R&D and manufacturing services, announces today that it is ranked the 83rd in Deloitte Technology Fast 500 Asian Pacific 2005 annual competition. The program is a ranking of the 500 leading technology companies across the Asia Pacific region based on percentage revenue growth over five years. From 2001 to 2005, WuXi PharmaTech grew more than 100 times.

This is the second consecutive award WuXi PharmaTech has received from Deloitte. The company was the 9th winner of Deloitte Technology Fast 500 Asia Pacific 2004 last year and most recently was ranked the 22rd in Deloitte Technology Fast 50 China.

"It is a good achievement and we are very proud and pleased to win the award again," WuXi PharmaTech's Chairman & CEO Dr. Ge Li said when heard the news. "WuXi PharmaTech has come of age in 2005 as we set our course to becoming a great service company. The company and the management team have matured and become more sophisticated in many ways. We will continue to focus on building a stronger service platform for our partners."

The winning companies come from a variety of technology businesses and industry sectors from across Asian Pacific. It is calculated that 16.4% of the 500 winners are from China including Hong Kong, and 4% from the Bio-Pharmaceutical sector.

About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top